Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × CYP3A Phenotyping × Docetaxel × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Prostatic Neoplasms 13 Breast Neoplasms 6 Nasopharyngeal Carcinoma 4 Neoplasm Metastasis 3 Carcinoma, Non-Small-Cell Lung 3 Malnutrition 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Recurrent Squamous Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Nonsquamous Nonsmall Cell Neoplasm of Lung 1 Neurotoxicity Syndromes 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer 1 Lung Neoplasms 1 Liver Neoplasms 1 Gallbladder Neoplasms 1 Fatigue 1 Esophageal Neoplasms 1 Chemotherapy-induced Peripheral Neuropathy 1 CYP3A Phenotyping 1 Biliary Tract Neoplasms 1

Interventions

Docetaxel 1 CEF regimen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01110291 2010-04-27

Docetaxel

University of Turku

CYP3A Phenotyping

Data powered by HemOnc (CC BY 4.0) Colophon ⚡